Jeff E. Knight, Chief Operating Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 1,152 shares at $20.70 ($24K) on 2022-07-26, disclosed to the SEC on 2022-07-29.
Open-market sale of $24k CRNX by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CRNX | SELL | 2025-03-21 | $477K | — | Filing → |
| CRNX | SELL | 2024-11-26 | $28K | — | Filing → |
| CRNX | SELL | 2024-07-17 | $1.5M | — | Filing → |